Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model

被引:9
|
作者
Wang, Lei [1 ,2 ]
Sun, Ximeng [2 ]
Huang, Jingjing [2 ]
Zhan, Bin [3 ]
Zhu, Xinping [2 ,4 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Beijing Trop Med Res Inst, Beijing, Peoples R China
[2] Capital Med Univ, Sch Basic Med Sci, Dept Med Microbiol & Parasitol, Beijing, Peoples R China
[3] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA
[4] Capital Med Univ, Res Ctr Microbiome, Beijing, Peoples R China
来源
FRONTIERS IN MICROBIOLOGY | 2017年 / 8卷
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Trichinella spiralis; vaccine; prime-boost; mucosal immunity; Salmonella typhimurium; HUMAN TRICHINOSIS; BALB/C MICE; STRATEGIES; EPIDEMIOLOGY; CHINA; CONSUMPTION; PARAMYOSIN; RESPONSES; VACCINES; PHASE;
D O I
10.3389/fmicb.2017.01394
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
TsPmy is a paramyosin expressed by parasitic Trichinella spiralis and confers a protective immunity when its recombinant protein or DNA was used as an immunogen. To improve its immunogenicity and vaccine efficacy, we conducted a heterologous prime-boost strategy by orally delivering one dose of TsPmy DNA carried by attenuated Salmonella typhimurium (SL7207), followed by two doses of recombinant TsPmy intramuscularly. This strategy effectively induced intestinal mucosal sIgA response and an enhanced and balanced Th1/Th2 immune responses that improve protection against T. spiralis larval challenge, with 55.4% muscle larvae reduction and 41.8% adult worm reduction compared to PBS control. The muscle larvae reduction induced by heterologous primeboost regimen was significant higher than that induced by the homologous DNA or protein prime-boost regimens, which could act as a practical prophylactic approach to prevent T. spiralis infection.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi
    Alberti, Andres Sanchez
    Bivona, Augusto E.
    Matos, Marina N.
    Cerny, Natacha
    Schulze, Kai
    Weissmann, Sebastian
    Ebensen, Thomas
    Gonzalez, German
    Morales, Celina
    Cardoso, Alejandro C.
    Cazorla, Silvia, I
    Guzman, Carlos A.
    Malchiodi, Emilio L.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [32] Phage-displayed specific polypeptide antigens induce significant protective immunity against Trichinella spiralis infection in BALB/c mice
    Cui, Jing
    Ren, Hui Jun
    Liu, Ruo Dan
    Wang, Li
    Zhang, Zi Fang
    Wang, Zhong Quan
    VACCINE, 2013, 31 (08) : 1171 - 1177
  • [33] Evaluation of protective efficacy induced by different heterologous prime-boost strategies encoding triosephosphate isomerase against Schistosoma japonicum in mice
    Dai, Yang
    Zhao, Song
    Tang, Jianxia
    Xing, Yuntian
    Qu, Guoli
    Dai, Jianrong
    Jin, Xiaolin
    Wang, Xiaoting
    PARASITES & VECTORS, 2017, 10
  • [34] Oral Vaccination of Mice With Trichinella spiralis Putative Serine Protease and Murine Interleukin-4 DNA Delivered by Invasive Lactiplantibacillus plantarum Elicits Protective Immunity
    Xue, Ying
    Zhang, Bo
    Wang, Nan
    Huang, Hai-Bin
    Quan, Yu
    Lu, Hui-Nan
    Zhu, Zhi-Yu
    Li, Jun-Yi
    Pan, Tian-Xu
    Tang, Yue
    Jiang, Yan-Long
    Shi, Chun-Wei
    Yang, Gui-Lian
    Wang, Chun-Feng
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [35] Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer
    Dai, Ming-Shen
    Vassaux, Georges
    Xu, Man
    You, Ren-In
    Hsieh, Yu-Feng
    Ouisse, Laure-Helene
    Lo, Kai-Yu
    Sytwu, Huey-Kang
    Chao, Tsu-Yi
    VACCINE, 2012, 30 (48) : 6903 - 6911
  • [36] T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine
    Li, Junwei
    Arevalo, Maria T.
    Chen, Yanping
    Chen, Shan
    Zeng, Mingtao
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 27 : 37 - 43
  • [37] A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine
    Liu, Yu
    Li, Miao
    Cui, Tingting
    Chen, Zhian
    Xu, Liangting
    Li, Wenjuan
    Peng, Qinhua
    Li, Xingxing
    Zhao, Danhua
    Valencia, C. Alexander
    Dong, Biao
    Wang, Zhongfang
    Chow, Hoi Yee
    Li, Yuhua
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (03)
  • [38] Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization
    Lapuente, Dennis
    Fuchs, Jana
    Willar, Jonas
    Antao, Ana Vieira
    Eberlein, Valentina
    Uhlig, Nadja
    Issmail, Leila
    Schmidt, Anna
    Oltmanns, Friederike
    Peter, Antonia Sophia
    Mueller-Schmucker, Sandra
    Irrgang, Pascal
    Fraedrich, Kirsten
    Cara, Andrea
    Hoffmann, Markus
    Poehlmann, Stefan
    Ensser, Armin
    Pertl, Cordula
    Willert, Torsten
    Thirion, Christian
    Grunwald, Thomas
    Ueberla, Klaus
    Tenbusch, Matthias
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [39] A prime-boost vaccination strategy using attenuated Salmonella typhimurium and a replication-deficient recombinant adenovirus vector elicits protective immunity against human respiratory syncytial virus
    Fu, Yuan-Hui
    He, Jin-Sheng
    Wang, Xiao-Bo
    Zheng, Xian-Xian
    Wu, Qiang
    Xie, Can
    Zhang, Mei
    Wei, Wei
    Tang, Qian
    Song, Jing-Dong
    Qu, Jian-Guo
    Hong, Tao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 395 (01) : 87 - 92
  • [40] A heterologous prime-boost route of vaccination based on the truncated MrpH adhesin and adjuvant properties of the flagellin from Proteus mirabilis against urinary tract infections
    Karam, Mohammad Reza Asadi
    Shirzad, Ali Mohammad
    Habibi, Mehri
    Bouzari, Saeid
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 58 : 40 - 47